BTG1 and B-cell chronic lymphocytic leukemia: Complex clonal shifts including mitochondrial metabolic reprogramming with altered expression of the AMPK signaling pathway, or mutations in BTG1 and aberrations of CDKN2A/B have been observed in venetoclax-resistant CLL [66,71].